Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ES-SCLC”

148 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 148 results

Not applicableNot Yet RecruitingNCT06530797
What this trial is testing

Real-World Cohort Study of Adebrelimab Injection in the Treatment of Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Shanghai Pulmonary Hospital, Shanghai, China 2,000
Testing effectiveness (Phase 2)Study completedNCT04636762
What this trial is testing

Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Second Xiangya Hospital of Central South University 40
Testing effectiveness (Phase 2)Looking for participantsNCT07155174
What this trial is testing

Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
AbbVie 180
Testing effectiveness (Phase 2)UnknownNCT05731518
What this trial is testing

SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Who this might be right for
Small Cell Lung Cancer
Biocity Biopharmaceutics Co., Ltd. 67
Large-scale testing (Phase 3)Looking for participantsNCT07472517
What this trial is testing

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy

Who this might be right for
Small Cell Lung Cancer (SCLC)Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Boehringer Ingelheim 670
Testing effectiveness (Phase 2)UnknownNCT04985201
What this trial is testing

Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

Who this might be right for
Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 40
Testing effectiveness (Phase 2)Ended earlyNCT04923776
What this trial is testing

Liver Directed RT + Chemo-immunotherapy for ES-SCLC

Who this might be right for
Small-cell Lung Cancer
Brian Henick, MD 2
Early research (Phase 1)Looking for participantsNCT04170946
What this trial is testing

Talazoparib and Thoracic RT for ES-SCLC

Who this might be right for
Lung CancerSmall-Cell Lung Cancer
University Health Network, Toronto 24
Early research (Phase 1)UnknownNCT05001412
What this trial is testing

Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Zhou Chengzhi 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT05844150
What this trial is testing

PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC

Who this might be right for
SCLC
Biotheus Inc. 50
Testing effectiveness (Phase 2)UnknownNCT05092412
What this trial is testing

Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

Who this might be right for
Lung CancerExtensive-stage Small-cell Lung CancerDurvalumab
You Lu 30
Testing effectiveness (Phase 2)Looking for participantsNCT06739928
What this trial is testing

Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Guangzhou Institute of Respiratory Disease 120
Not applicableLooking for participantsNCT07244016
What this trial is testing

Clinical Study on Using TCR to Predict the Effect of Tislelizumab + Chemotherapy in the First-line Treatment of ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Henan Cancer Hospital 40
Not applicableNot Yet RecruitingNCT06982287
What this trial is testing

A Retrospective Real-World Study on the Efficacy and Safety of Anlotinib Hydrochloride Combined With Immunotherapy Maintenance Therapy Following Standard Chemoimmunotherapy for ES-SCLC (ALTER-L059)

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Yong Fang 100
Testing effectiveness (Phase 2)Study completedNCT02182050
What this trial is testing

Efficacy and Safety of Oral Treatment With BIBF 1120 ES in Advanced Non-small-cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT05142696
What this trial is testing

[177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Novartis Pharmaceuticals 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06306560
What this trial is testing

Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Harbin Medical University 40
Large-scale testing (Phase 3)Looking for participantsNCT07005128
What this trial is testing

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

Who this might be right for
Small-cell Lung CancerExtensive Stage Small-cell Lung Cancer
Amgen 330
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06793228
What this trial is testing

Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia

Who this might be right for
SCLC, Extensive Stage
Henan Cancer Hospital 250
Large-scale testing (Phase 3)Study completedNCT02763579
What this trial is testing

Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Carcinoma
Hoffmann-La Roche 503
Load More Results